- Home
- UHT vs KMDA Comparison
UHT vs KMDA Comparison
Compare UHT & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UHT | KMDA |
|---|---|---|
| Founded | 1986 | 1990 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 540.9M | 458.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | UHT | KMDA |
|---|---|---|
| Price | $42.10 | $8.21 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | 67.8K | ★ 78.5K |
| Earning Date | 02-25-2026 | 03-04-2026 |
| Dividend Yield | ★ 7.08% | 2.44% |
| EPS Growth | N/A | ★ 30.41 |
| EPS | ★ 1.30 | 0.35 |
| Revenue | $100,898,000.00 | ★ $174,787,000.00 |
| Revenue This Year | $0.71 | $14.79 |
| Revenue Next Year | $2.00 | $11.38 |
| P/E Ratio | $32.41 | ★ $22.91 |
| Revenue Growth | 1.00 | ★ 10.36 |
| 52 Week Low | $35.26 | $5.54 |
| 52 Week High | $43.10 | $9.16 |
Technical Indicators
Market Signals| Indicator | UHT | KMDA |
|---|---|---|
| Relative Strength Index (RSI) | 70.89 | 52.06 |
| Support Level | $38.11 | $7.94 |
| Resistance Level | $40.40 | $8.88 |
| Average True Range (ATR) | 0.88 | 0.22 |
| MACD | 0.41 | -0.07 |
| Stochastic Oscillator | 100.00 | 30.33 |
Price Performance
Historical ComparisonAbout UHT Universal Health Realty Income Trust
Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio, located throughout the United States.
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.